Florfenicol

Producers shown on SFDA

(Record date:09/09/2021）

Producers shown on EP

Not showing any

Producer:An'hui Liberty Pharmaceutical Co., Ltd., established in 2008, is a wholly foreign-owned enterprise integrating pharmaceutical scientific research, production and sales.

The company covers an area of 140000 square meters. The production plant is designed and constructed in accordance with the requirements of FDA, egmp and GMP, adopts domestic and foreign advanced production equipment and testing instruments, and has established a strict and efficient quality management assurance system. With nearly 300 employees and an annual production capacity of 1000 tons of API, the products sell well in European and American markets.

Staff size:300-399 people

Registered capital:USD 15 million

Producer:Zhejiang Kangmu Pharmaceutical Co., Ltd. (Group) was founded in 2003.

The company covers an area of 93.55 Mu and a plant construction area of 32000 square meters. It is a modern enterprise producing flufenicol and tilmicosin series raw materials. The company's products have passed the GMP certification of the Ministry of agriculture and obtained the production license and approval number.

Staff size:200-299 people
Registered capital:RMB 23 million

Producer:Hubei Zhongmu Anda Pharmaceutical Co., Ltd. is a large high-tech enterprise integrating scientific research, development, production and sales of chemical synthetic veterinary drug raw materials and preparations and feed additives. The company obtained the enterprise GMP certificate in 2005, with an annual production of more than 5000 tons of various veterinary drug raw materials and preparations.

Staff size:200-299 people

Registered capital:RMB 61.25 million

Producer:Henan Houyi Pharmaceutical Co., Ltd. is subordinate to Henan Houyi industrial group. The company covers an area of 800 mu, with a fermentation tonnage of 4000 tons and a synthesis capacity of 13800 tons. After completion, it will be a large production base of veterinary API in the Central Plains.

The company's main product production line has passed GMP acceptance, and the annual sales of sulfamethoxam and Cyclopropylamine are 500 tons and 1000 tons respectively; After tylosin and acetylisovaleryl tylosin are launched, the annual output can reach 500 tons and 200 tons.

Staff size:50-99 people

Registered capital:RMB 128 million

Producer:Zhengzhou Fuyuan Animal Pharmaceutical Co., Ltd., established in 2002, is composed of three economic entities: Fuyuan animal protection, Fuyuan Chemical Industry and Fuyuan Technology. The company mainly produces and sells veterinary APIs and preparations. The company has passed GMP and FDA certification.

Staff size:50-99 people

Registered capital:RMB 100 million

Registered capital:RMB 14.5 million

Producer:Jingshan Ruisheng Pharmaceutical Co., Ltd., a subsidiary of ruifuxin Jiangsu Pharmaceutical Co., Ltd., was established in 2008, covering an area of more than 40000 square meters.

It mainly produces and operates flufenicol API products and passed the national veterinary drug GMP review at the end of 2019.

Registered capital:RMB 35 million

Producer:Jiangsu Hansyn Pharmaceutical Co., Ltd. was established in 2002. Its products involve florfenicol, thiamphenicol and related products. Hengsheng pharmaceutical is the world's largest production base of florfenicol and Thiamphenicol APIs, and has industry-leading R & D, production and processing technology in the field of API molecular coating.

Staff size:200-299 people

Registered capital:RMB 120 million

Producer:Shandong Guobang Pharmaceutical Co., Ltd., established in December 2006, is a backbone enterprise subordinate to Guobang Pharmaceutical Group Co., Ltd. the company covers an area of nearly 1000 mu and passed the GMP certification of the Ministry of agriculture in 2013. The production capacity of the company's metal compound series products reaches 8500 tons / year, the production capacity of advanced amine series products reaches 7000 tons / year, and the production capacity of veterinary medicine series reaches 4000 tons / year.

Staff size:1000-1999 people
Registered capital:RMB 104.73 million

Producer:Hunan Norchem Pharmaceutical Co., Ltd., established in 2013, is a high-tech enterprise with the nature of industrial group integrating the R & D, production and sales of steroidal drugs. It governs two intermediate factories, a sex hormone API factory and a preparation factory, forming an industrial chain system integrating science, industry and trade. The company is applying for ISO14001 system certification and OHSAS18001 system certification to put the company's EHS system on track.

Staff size:400-499 people

Registered capital:RMB 26 million 426 thousand and 831

Producer:Zhejiang Hisoar Pharmaceutical Co.,Ltd. located in Taizhou, Zhejiang Province, is a listed company controlled by Donggang group, which mainly produces characteristic APIs, preparations, fine chemicals, dyes and dye intermediates.

The company's main products are antibiotics, cardiovascular, hypoglycemic and other APIs, fine chemicals, preparations, dyes and intermediates. More than 70% of pharmaceutical products are exported, and the output of clindamycin series is firmly in the leading position in the world. The company attaches great importance to the construction of EHS and GMP system. Dozens of products have registered with the US FDA, obtained the EU CEP (COS) certificate, passed the Japanese GMP certification and domestic GMP certification. Dye products are exported to more than 30 countries and regions such as Europe, America and Asia. The leading product reactive brilliant blue KN-R accounts for more than 60% of the global market share. It is in a leading position in the industry in terms of industrial scale, technical quality and product application“ "Dye eight brand" reactive dyes are rated as China's famous brand products and national excellent torch plan projects. They are one of the three famous brand dyes in China.

Staff size:About 500 people

Registered capital:RMB 1 billion 618 million 715 thousand and 253 

Producer:Shaoxing Minsheng Pharmaceutical Co., Ltd., established in 2002, is a subsidiary of Hangzhou Minsheng pharmaceutical Holding Group Co., Ltd.

The company produces more than 20 kinds of semi synthetic pharmaceutical raw materials such as alanyl glutamine, praziquantel, thiadiazine series, scopolamine series and vinblastine series. Among them, 9 products have passed FDA certification.

Staff size:500-599 people

Registered capital:RMB 88 million

Staff size:About 50 people

Registered capital:RMB 26 million

Producer:Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. is a member enterprise of Hengdian group, focusing on the R & D, production and sales of cephalosporin antibiotic APIs and pharmaceutical intermediates. It is the largest manufacturer of cefixime in China.

The company has passed iso9001a international quality system certification and ISO14001 environmental quality system certification. Among the company's existing products, cefixime and cefdinir APIs have passed the new GMP certification, florfenicol APIs have passed the GMP certification of veterinary drugs, oz has passed the PMDA certification of Japan, TTA and florfenicol have passed the FDA certification of the United States, and have passed the quality audit of Novartis, Roche, Merck and other large international companies, establishing a long-term friendly cooperative relationship with the world pharmaceutical giants.

Staff size:500-599 people

Registered capital:RMB 130 million

Producer:Zhejiang Runkang Pharmaceutical Co., Ltd. is a comprehensive enterprise producing pharmaceutical preparations, APIs, veterinary APIs and intermediates.

The leading products of Zhejiang runkang Pharmaceutical Co., Ltd. include methylsulfonomycin, florfenicol, ciprofloxacin hydrochloride and other veterinary drug raw materials. The annual output is more than 1 billion tablets and capsules, and more than 1000 tons of various APIs. At present, 38 products have passed GMP certification.

Staff size:About 50 people

Registered capital:RMB 31.8 million

Producer:Hubei Masteam Bio-tech Co.,Ltd. was established in 2009, covering an area of more than 100000 square meters, a standardized GMP workshop of more than 30000 square meters, and a main production workshop of more than 15000 square meters. The company is committed to developing and producing high-efficiency, low toxicity and no residue animal specific veterinary products and important pharmaceutical intermediates. All products have passed GMP certification.

Staff size:400-499 people

Registered capital:RMB 54 million 423 thousand and 700

Producer:Jiaozuo Kaisen Pharmaceutical Co., Ltd. was founded in 2006, covering an area of more than 50000 square meters. It has newly built a powder injection production line, three water injection production lines, five solid production lines, two disinfectant production lines, doxycycline raw material production line and traditional Chinese medicine extraction production line. It will achieve an annual production capacity of 10 million bags of veterinary powder, 100 million pieces of water injection and powder injection, 500000 bottles of disinfectant and 450 tons of doxycycline API.

Staff size:/

Registered capital:RMB 15 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +8618402846978